Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Mayo Clinic research: Missouri startup’s VR tech can help calm patients’ pre-surgery jitters
A recent study from the renowned researchers at the Mayo Clinic suggests a dose of virtual reality can help reduce pre-op anxiety in older patients undergoing their first open-heart surgery — and their findings come after testing with technology from Columbia, Missouri-based Healium. “While much of the research to date using VR involved younger patient…
City Market eats: Master roaster hopes hungry Kansas Citians will flock to Murmuration
A new eatery and cocktail bar that now shares a space with the popular City Market Coffee Roasters is designed to reflect a vision of bringing people together, fostering connection, and embracing the diversity that makes the City Market so special, said master roaster Nikole Ammer. Plus, the people are hungry — from day to…
Chamber showcase fills Union Station with real-life social networking for small biz owners
Entrepreneur Dane Moss likes to do things a little over the top, he shared Wednesday from inside the Grand Hall at Union Station, noting that simply handing out T-shirts and koozies to event attendees simply doesn’t fit his style. So for his first KC Chamber Small Business Celebration Candidates’ Showcase, Moss and his team from…
1 Million Cups relocating back to Kauffman Foundation, renewing weekly meetup’s energy, sense of purpose
After more than six years connecting entrepreneurs in Midtown, 1 Million Cups Kansas City is returning to its roots — relocating the weekly event series April 9 to the Kauffman Foundation Conference Center where the now-coast-to-coast morning meetup series first percolated. Changing the brew for the Wednesday entrepreneur pitch showcase came from the same voices…